Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.22.2
Accrued Expenses
6 Months Ended
Jun. 30, 2022
Payables And Accruals [Abstract]  
Accrued Expenses

8. Accrued Expenses

Accrued expenses consisted of the following as of June 30, 2022 and December 31, 2021 (in thousands):

 

 

 

June 30, 2022

 

 

December 31, 2021

 

External research and preclinical development

 

$

12,454

 

 

$

8,274

 

Employee compensation and benefits

 

 

5,484

 

 

 

6,344

 

Professional fees

 

 

2,511

 

 

 

953

 

Facilities and other

 

 

30

 

 

 

53

 

Accrued expenses

 

$

20,479

 

 

$

15,624